Details for Patent: 5,733,569
✉ Email this page to a colleague
Summary for Patent: 5,733,569
Title: | Galenic compositions comprising calcitonin and their use |
Abstract: | Pharmaceutical compositions for nasal administration comprising i) a calcitonin, and ii) benzalkonium chloride, and/or iv) a surfactant, suitable for application to the nasal mucosa, in iii) a liquid diluent or carrier, suitable for application to the nasal mucosa. The compositions are suitably adapted for administration in the form of a nasal spray. |
Inventor(s): | Azria; Moise (Basel, CH), Cavanak; Thomas (Biel-Benken, CH) |
Assignee: | Novartis Corporation (Summit, NJ) |
Application Number: | 08/471,118 |
Patent Claim Types: see list of patent claims | Composition; Delivery; Device; Use; | More… ↓ |
Drugs Protected by US Patent 5,733,569
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,733,569
International Family Members for US Patent 5,733,569
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 394947 | ⤷ Subscribe | |||
Austria | 402895 | ⤷ Subscribe | |||
Austria | A259288 | ⤷ Subscribe | |||
Austria | A349483 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |